review

Artificial intelligence and radiomics: fundamentals, applications, and challenges in immunotherapy
Laurent Dercle, Jeremy McGale, Shawn Sun, Aurelien Marabelle, Randy Yeh, Eric Deutsch, Fatima-Zohra Mokrane, Michael Farwell, Samy Ammari, Heiko Schoder, Binsheng Zhao, Lawrence H Schwartz

Journal for ImmunoTherapy of Cancer Sep 2022, 10 (9) e005292; DOI: 10.1136/jitc-2022-005292
OxMIF: a druggable isoform of macrophage migration inhibitory factor in cancer and inflammatory diseases
Michael Thiele, Seamas C Donnelly, Robert A Mitchell

Journal for ImmunoTherapy of Cancer Sep 2022, 10 (9) e005475; DOI: 10.1136/jitc-2022-005475
Peptide emulsions in incomplete Freund’s adjuvant create effective nurseries promoting egress of systemic CD4⁺ and CD8⁺ T cells for immunotherapy of cancer
Marit M Melssen, Caroline T Fisher, Craig L Slingluff, Cornelis J M Melief

Journal for ImmunoTherapy of Cancer Sep 2022, 10 (9) e004709; DOI: 10.1136/jitc-2022-004709
TIGIT-CD226-PVR axis: advancing immune checkpoint blockade for cancer immunotherapy
Eugene Y Chiang, Ira Mellman

Journal for ImmunoTherapy of Cancer Apr 2022, 10 (4) e004711; DOI: 10.1136/jitc-2022-004711
The use of oncolytic virotherapy in the neoadjuvant setting
Raquela J Thomas, Eric Bartee

Journal for ImmunoTherapy of Cancer Apr 2022, 10 (4) e004462; DOI: 10.1136/jitc-2021-004462
Considerations for treatment duration in responders to immune checkpoint inhibitors
Thomas U Marron, Aideen E Ryan, Sangeetha M Reddy, Sabina Kaczanowska, Rania H Younis, Dipti Thakkar, Jiajia Zhang, Todd Bartkowiak, Rachel Howard, Kristin G Anderson, Daniel Olson, Abdul Rafeh Naqash, Ravi B Patel, Esha Sachdev, Maria E Rodriguez-Ruiz, Michal Sheffer, Sarah Church, Christopher Fuhrman, Abigail Overacre-Delgoffe, Rosa Nguyen, Vaia Florou, Jessica E Thaxton, David H Aggen, Jennifer L Guerriero

Journal for ImmunoTherapy of Cancer Mar 2021, 9 (3) e001901; DOI: 10.1136/jitc-2020-001901
Role of Fcγ receptors in HER2-targeted breast cancer therapy
Antonino Musolino, William J Gradishar, Hope S Rugo, Jeffrey L Nordstrom, Edwin P Rock, Fernanda Arnaldez, Mark D Pegram

Journal for ImmunoTherapy of Cancer Jan 2022, 10 (1) e003171; DOI: 10.1136/jitc-2021-003171
Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis
Alice Tzeng, Tony H Tzeng, Moshe C Ornstein

Journal for ImmunoTherapy of Cancer Oct 2021, 9 (10) e003473; DOI: 10.1136/jitc-2021-003473
Immune checkpoint inhibitor treatment and atherosclerotic cardiovascular disease: an emerging clinical problem
Kikkie Poels, Suzanne I.M. Neppelenbroek, Marie José Kersten, M. Louisa Antoni, Esther Lutgens, Tom T.P. Seijkens

Journal for ImmunoTherapy of Cancer Jun 2021, 9 (6) e002916; DOI: 10.1136/jitc-2021-002916
Implications of mRNA-based SARS-CoV-2 vaccination for cancer patients
Emanuela Romano, Steve Pascolo, Patrick Ott

Journal for ImmunoTherapy of Cancer Jun 2021, 9 (6) e002932; DOI: 10.1136/jitc-2021-002932

Main menu

review

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

review

Pages